Boston Scientific (BSX) Debt to Equity (2016 - 2025)
Boston Scientific (BSX) has disclosed Debt to Equity for 17 consecutive years, with $0.47 as the latest value for Q4 2025.
- Quarterly Debt to Equity fell 4.32% to $0.47 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.47 through Dec 2025, down 4.32% year-over-year, with the annual reading at $0.47 for FY2025, 4.32% down from the prior year.
- Debt to Equity hit $0.47 in Q4 2025 for Boston Scientific, down from $0.5 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $529.71 in Q1 2023 to a low of -$681.59 in Q2 2025.
- Historically, Debt to Equity has averaged -$3.65 across 5 years, with a median of $0.48 in 2022.
- Biggest five-year swings in Debt to Equity: skyrocketed 18175.35% in 2021 and later plummeted 14413.81% in 2025.
- Year by year, Debt to Equity stood at $0.45 in 2021, then crashed by 975.14% to -$3.97 in 2022, then surged by 111.74% to $0.47 in 2023, then rose by 4.79% to $0.49 in 2024, then dropped by 4.32% to $0.47 in 2025.
- Business Quant data shows Debt to Equity for BSX at $0.47 in Q4 2025, $0.5 in Q3 2025, and -$681.59 in Q2 2025.